Active Product 1.1 for Abdominal Pain

"Individuals aged between 21 and 105 with a gastrointestinal ailment are eligible to participate in this trial, which aims to admit a total of 500 participants."

"Affirmative. Information available on clinicaltrials.gov indicates that this particular medical trial is actively enrolling participants. The trial was initially uploaded on March 19, 2024, and the most recent update occurred on April 18, 2024. The study aims to recruit a total of 500 patients from one designated site."

"Affirmative. Data available on clinicaltrials.gov highlights that this research endeavor is actively pursuing eligible participants. The trial was initially disclosed on March 19, 2024, and its latest update was recorded on April 18, 2024. A total of 500 individuals are being sought from a singular site for inclusion in the study."

"According to data provided by the clinical trial sponsor, Radicle Science, the main focus of this study will be on assessing alterations in GI (Gastrointestinal) Health over a period of 6 weeks. Additionally, secondary outcomes under scrutiny comprise identifying Minimal Clinically Important Differences (MCID) in GI Health for various parameters including Gastrointestinal Constipation intensity based on PROMIS scale 5-45; where higher scores indicate more severe constipation symptoms and Belly Pain severity measured on a scale from 2-25; with elevated values indicating increased abdominal discomfort. Furthermore, Gas and Bloating levels ranging between 2 to 60 are also"

"To be eligible for this research, individuals between the ages of 21 and 105 are sought. There are separate studies available for those under 18 and over 65 years old: 18 studies cater to pediatric patients while there are 20 trials tailored towards elderly participants."